Navigation Links
New research explores newborn in-hospital weight loss
Date:8/21/2007

Healthy, full-term newborn babies tend to lose weight during the first few days after their birth. A groundbreaking new study published in the latest issue of the Journal of Human Lactation explores the reasons why certain newborns lose more (or less) than others and what conclusions can be drawn from the research.

The purpose of the study, published by SAGE in the Journal of Human Lactation, for the International Lactation Consultant Association, was to determine the factors associated with in-hospital weight loss of healthy, full-term newborns, including birth and infant-feeding factors as well as maternal and newborn demographics.

The study found a substantial difference in weight loss between exclusively breastfed and completely formula-fed newborns, which lost less. That disparity led the researchers to conjecture that formula-fed infants may be at risk of early overfeeding. Supplemented breastfed infants had similar weight loss patterns to the exclusively breastfed newborns.

Degree of weight loss is critical in the decision to supplement breastfed infants with formula, write the studys authors, Patricia J. Martens, IBCLC, PhD, and Linda Romphf, IBCLC. However, given the overhydration of newborns, the early loss of meconium, and small fluid intake in the first few days, loss of 5-7% of birth weight is considered physiologically appropriate.

Newborn feeding experiences may be critical in metabolic imprinting and may factor into adult weight. The most influential predictor of weight loss in newborns is the type of infant feeding, conclude the authors. Further study is critical, especially in light of current research on the association between early weight gain of formula-fed infants and adult obesity. Breastfeeding-supportive environments are necessary to support and enable women to breastfeed.


'/>"/>
Contact: Judy Erickson
media.inquiries@sagepub.com
SAGE Publications
Source:Eurekalert

Page: 1

Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Stem cell research- now Nobel Laureates join the debate
3. Researchers urge caution in using ear tube surgery
4. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
5. Spouses and other partners lower blood pressure says new research
6. Researchers Scale to assess the Severity of Epilepsy in Kids
7. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
8. Research of Ritalin
9. New Hair in 15 Days Could Now Be A Possibility Say Researchers
10. Researchers at Cornell University as been reported using research fund by false claims
11. Better Research Rats To Help In Learning About Hypertension

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... Freeze-drying of biopharmaceuticals to be avail...acility. , Toronto, ON (...nt and CEO of Therapure Biopharma Inc. today annou...ercial scale pharmaceutical grade freeze dryer and...yophilization) available for contract manufacturin...
(Date:11/8/2009)...s not mean the battle is won," said Dr. Charmaine ...swire/ -- In a vote of 240-194, the Stupak-Ellswor...t to prohibit abortion mandates and funding in HR ...ited for Life Action President and CEO Dr. Charmai... victory for the pro-life Americans across this co...
(Date:11/8/2009)...Passage of H.R. 3961 to Secure the Stability of Me...re/ -- Statement Attributable to: J. James Rohack,..., (Logo: http://www.newscom.com/cgi-bin/prnh/2...ge of the House health reform bill, which will hel...cians and calls for swift passage of H.R. 3961 to ...
(Date:11/8/2009)...se Passage of Health Care Reform Bill ,, Crit...e coverage for all Americans ,, BALTIMORE, Nov...the United States House of Representatives passed ... strengthen Medicare for seniors and end discrimin...of Americans out of affordable health coverage. ,...
(Date:11/7/2009)... The American Medical As...sh Award for Citizenship and Community Service to ...ago, IL. The award recognizes physicians who have ...uty to make an outstanding public service contribu...the award today during the opening session of the ...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
...uster Active Noise Reduction Earmuff Delivers Best...The NoiseBuster Active Noise Reduction ("ANR") Saf... noise generated by lawn, landscape and garden pow...scape construction, sports-field site development ...
... 23 Consider how these outlooks could free you fr... change the way you look at them. , Problems... , , , "Thus I Became Stress Free, Oh Really?...and happiness. Written from the inspiration Joshi ...
...alist HIDI(TM) process at the 2009 Annual Congress..., , SEATTLE, March 23 Hospital executives find t...ith almost 50 percent of America,s hospitals now o...y and retaining physicians and caregivers. The cha...
...orphotek(R), Inc., a subsidiary of Eisai Corporati... Food and Drug Administration (FDA) has agreed to ...e III clinical trial evaluating farletuzumab (also... Assessment (SPA) procedure. , , "We are pleased ...
...h.D. Honored for Distinguished Service in the Fiel...NovaBay Pharmaceuticals, Inc. (NYSE Alternext: NBY... Frederick Hawthorne, Ph.D., a member of the Compa...r. Hawthorne, who is co-director of the Internatio...
...wire-FirstCall/ - Transition Therapeutics Inc. ("T...TTH) announced today that the first patient has be...T-223 in combination with a proprietary Lilly GLP-...ate the safety, tolerability and efficacy of daily...
Other Medicine News:Health News:NoiseBuster(R) Safeguards Hearing by Utilizing Cutting-Edge Technology to Attenuate Power Equipment Noise 2Health News:'Thus I Became Stress Free, Oh Really?': Systematically Manage and Optimize Stress to Improve Productivity, Happiness 2Health News:Sound Inpatient Physicians Report on New Clinical Processes to Reduce Healthcare Costs and Enhance Care 2Health News:Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 2Health News:Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 3Health News:Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 4Health News:NovaBay Pharmaceuticals' Scientific Advisor Receives American Chemical Society's Highest Award 2Health News:NovaBay Pharmaceuticals' Scientific Advisor Receives American Chemical Society's Highest Award 3Health News:Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes 2
(Date:11/7/2009)... BEACH, Fla., Nov. 7 Patients repo... an effective therapy in treating acute swelling a...rious genetic disorder, according to data presente...sthma & Immunology (ACAAI) Annual Meeting. The...nts conducted in parallel with the ongoing, prospe...
(Date:11/6/2009)...LL, Wash., Nov. 6 SCOLR ...l results for the three and nine months ended Sept...harma,s President and CEO, said, "We continue to a...r ibuprofen formulation. Several potential partner...rsonnel and external resources as they evaluate th...
(Date:11/6/2009)...OUIS, Nov. 6 Recession i...depress sales for Allied Healthcare Products in th...er 30, 2009. ,, Sales declines pushed Allied in...uarter was about $745,000, or negative 9 cents per...of about $208,000, or 3 cents per share. ,, Sa...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Discovering soybean plants resistant to aphids and a new aphid 9530 1Discovering soybean plants resistant to aphids and a new aphid 9530 2Discovering soybean plants resistant to aphids and a new aphid 9530 3Discovering soybean plants resistant to aphids and a new aphid 9530 4PLUS Diagnostics Announces Senior Executive Appointments 54089 1PLUS Diagnostics Announces Senior Executive Appointments 54089 2PLUS Diagnostics Announces Senior Executive Appointments 54089 3Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 1Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 2Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 3
... (Zurich), Switzerland, May 24, 2007 - Cytos,Biote... a,placebo-controlled, double-blind combined phase...ndidate for the treatment of,psoriasis and other i...rst-time-in-man clinical trial and included 48 pat...riasis. In a first part,of the study, the safety a...
... Mass.--(BUSINESS WIRE)--May 24, 2007 - ImmunoGen,...that develops targeted,anticancer therapeutics usi...oday announced that clinical findings for three,di...umors are to be,reported at the 43rd American Soci...take place June 1-5, 2007 in Chicago, IL., Trastuz...
Other Medicine Technology:Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 2Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 3Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 4ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3
Agarose, ultra high resolution, Molecular Biology Grade
AGAROSE I (Molecular Biology Grade)
Agarose, 500g
Agarose NA
Medicine Products: